ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Tafinlar 75 mg, Hartkapseln - 28 Kapsel(n)
62781003 Novartis Pharma Schweiz AG
Tafinlar 75 mg, Hartkapseln13.01.2014
  13.01.2014
Dabrafenib (L01EC02) 
WHO-DDD 
07.16.10.28 Kapsel(n)
07.16.10. 
A  
Yes 
IPCI
1230.27Yes
    
10 %1354.40
7680627810034Synthetika
5892753 
Composition
dabrafenibum 75.0 mg ut dabrafenibi mesilas, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: hypromellosum, E 171, E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Dabrafenibum75 mg
BAG: Active AgentDose
Dabrafenibum75 mg
 
Inactive agents additional_information
(Nigrum)  
(Rubrum)  
Ammonii Hydroxidum  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Hypromellosum Kapselhülle
Lacca Drucktinte
Magnesii Stearas  
Pro Capsula  
Propylenglycol  
Silica Colloidalis Anhydrica  
 
Source
Data was imported : 04.05.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home